ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
16 janv. 2024 08h00 HE
|
ClearPoint Neuro, Inc.
ClearPoint Neuro received 510(k) clearance for SmartFrame OR, first product in company history designed for the operating room instead of the MRI suite.
ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue
08 janv. 2024 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Reports Third Quarter 2023 Results
09 nov. 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023
26 oct. 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Reports Second Quarter 2023 Results
08 août 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Announce Second Quarter 2023 Results August 8, 2023
25 juil. 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro en UCB gaan licentieovereenkomst aan voor toediening van gentherapiegeneesmiddelen
25 mai 2023 08h51 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Californië, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), een multinational die platforms ontwikkelt voor therapie met navigatie naar en levering aan de...
ClearPoint Neuro y UCB firman un acuerdo de licencia para la administración de fármacos de terapia génica
25 mai 2023 08h51 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, California, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), una empresa global de plataformas habilitadoras de terapias que ofrecen navegación y administración...
ClearPoint Neuro e UCB stipulano un contratto di licenza per la somministrazione di farmaci per la terapia genetica
25 mai 2023 08h51 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, California, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), società globale di piattaforme terapeutiche che fornisce navigazione e somministrazione al cervello,...
ClearPoint Neuro et UCB concluent un accord de licence pour l'administration de médicaments de thérapie génique
25 mai 2023 08h51 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Californie, 25 mai 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ : CLPT), une société mondiale de plateformes thérapeutiques permettant la navigation et l'administration vers...